Wednesday, November 25, 2009, 11:13am EST - Canadian Markets close in 4 hours and 47 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

STAAR Surgical Company (STAA)

At 10:57 EST: 3.81 USD  Down 0.03 (0.78%)  
MORE ON STAA
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
STAAR Surgical Company (NGM:STAA) Delayed quote dataEdit
Last Trade: 3.81 USD
Trade Time: 10:57AM EST
Change: Down 0.03 (0.78%)
Prev Close: 3.84
Open: 3.85
Bid: 3.80 x 100
Ask: 3.81 x 100
1y Target Est: 4.67
Day's Range: 3.77 - 3.84
52wk Range: 0.79 - 4.26
Volume: 1,700
Avg Vol (3m): 104,645
Market Cap: 132.32M
P/E (ttm): N/A
EPS (ttm): -0.46
Div & Yield: N/A (N/A%)
STAAR Surgical Company (STAA)
1d  5d  3m  6m  1y  2y  5y  max 
 Add STAA to Portfolio   Download Data

HEADLINES
STAAR SURGICAL CO Financials
EDGAR Online Financials (Wed, Nov 18)
Cashing In on Obamacare
at Motley Fool (Fri, Nov 13)
STAAR SURGICAL CO Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Nov 12)
STAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure
EDGAR Online (Mon, Nov 9)
STAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Fri, Nov 6)
STAAR Surgical Earnings Call scheduled for 10:00 am ET today
CCBN (Tue, Nov 3)
STAAR Surgical Generates $464,000 in Cash from Operations During Third Quarter Largest Amount of Cash from Operating Activities in More Than Six
PRNewswire (Mon, Nov 2)
Q3 2009 STAAR Surgical Earnings Release - After Market Close
CCBN (Mon, Nov 2)
STAAR Surgical Announces Third Quarter 2009 Earnings Release Date and Conference Call
PRNewswire (Tue, Oct 27)
STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
PRNewswire (Tue, Oct 27)
More Headlines for STAA...

ANALYST
EPS Est (next year) (Dec-09) : -0.18
EPS Est (in 2 years) (Dec-10) : 0.05
Avg Rec (current)*: 2.3
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
STAAR Surgical Company, together with its subsidiaries, develops, manufactures, and sells intraocular lenses (IOL), implantable collamer lenses (ICL), and ophthalmic surgical products used primarily in cataract and refractive surgery.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News Canadian Indices